HSP90B2P and cardiomyopathy: To further investigate the Hsp/c70 dependent cardioprotective effect of ILK we used Doxorubicin (DOX), an effective and frequently used chemotherapeutic agent for various malignancies, which causes both an acute and late-onset, dose-limiting cardiomyopathy[19,20].